Both western blotting and immunohistochemistry (IHC) analyses revealed upregulation of FAT10, TFRC, and ACSL4 expression, alongside a downregulation of FTH1 expression in pancreatic tissues of the AP group (Figs. 1I, J and S1B). The gene discussed is TFRC; the disease is alkaline phosphatase measurement.